Adimmune Corp (Taiwan) Today
| 4142 Stock | TWD 22.35 0.15 0.68% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Adimmune Corp is selling for under 22.35 as of the 22nd of November 2024; that is 0.68% increase since the beginning of the trading day. The stock's lowest day price was 22.15. Adimmune Corp has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Adimmune Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of December 2022 and ending today, the 22nd of November 2024. Click here to learn more.
Adimmune Corporation manufactures and sells human vaccines in Taiwan. Adimmune Corporation was founded in 1965 and is based in Taichung City, Taiwan. ADIMMUNE CORPORATION operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange. The company has 421.51 M outstanding shares. More on Adimmune Corp
Moving together with Adimmune Stock
| 0.86 | 1438 | SanDi Properties | PairCorr |
| 0.8 | 1516 | Falcon Power Split | PairCorr |
| 0.95 | 6785 | Alar Pharmaceuticals | PairCorr |
| 0.68 | 1435 | Chung Fu Tex | PairCorr |
| 0.91 | 1423 | Reward Wool Industry | PairCorr |
| 0.94 | 3465 | New Advanced Electronics | PairCorr |
Moving against Adimmune Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Adimmune Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Adimmune Corp's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Adimmune Corp or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Adimmune Corp (4142) is traded on Taiwan Stock Exchange in Taiwan and employs 36 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 17.01 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Adimmune Corp's market, we take the total number of its shares issued and multiply it by Adimmune Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Adimmune Corp operates under Biotechnology sector and is part of Health Care industry. The entity has 421.51 M outstanding shares.
Adimmune Corp has accumulated about 654.9 M in cash with (480.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.76.
Check Adimmune Corp Probability Of Bankruptcy
Ownership AllocationAdimmune Corp holds a total of 421.51 Million outstanding shares. Adimmune Corp shows 16.9 percent of its outstanding shares held by insiders and 15.86 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Adimmune Ownership Details
Adimmune Corp Risk Profiles
Although Adimmune Corp's alpha and beta are two of the key measurements used to evaluate Adimmune Corp's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.8478 | |||
| Standard Deviation | 1.16 | |||
| Variance | 1.36 | |||
| Risk Adjusted Performance | (0.24) |
Adimmune Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Adimmune Corp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Adimmune Corp Corporate Management
Elected by the shareholders, the Adimmune Corp's board of directors comprises two types of representatives: Adimmune Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Adimmune. The board's role is to monitor Adimmune Corp's management team and ensure that shareholders' interests are well served. Adimmune Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Adimmune Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fei Pan | Chief Legal Affairs Officer | Profile | |
| ChinChuan Chang | COO RD | Profile | |
| LiYa Tang | Director Center | Profile | |
| ChihHsiang Leng | Head Division | Profile | |
| ChungCheng Liu | GM Pres | Profile | |
| YinTeng Chang | Chief Officer | Profile | |
| MBA MD | Chief Officer | Profile |
Additional Tools for Adimmune Stock Analysis
When running Adimmune Corp's price analysis, check to measure Adimmune Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adimmune Corp is operating at the current time. Most of Adimmune Corp's value examination focuses on studying past and present price action to predict the probability of Adimmune Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adimmune Corp's price. Additionally, you may evaluate how the addition of Adimmune Corp to your portfolios can decrease your overall portfolio volatility.